UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis

Journal of thrombosis and haemostasis, 2013-02, Vol.11 (2), p.315-324

2013

Volltextzugriff (PDF)

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

Thrombosis and haemostasis, 2001-10, Vol.86 (4), p.954-958

2001

Volltextzugriff (PDF)

Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: Results from a multicenter study in 47 patients

Circulation (New York, N.Y.), 2004-02, Vol.109 (6), p.740-744

2004

Volltextzugriff (PDF)

Inhibitors in haemophilia B: the Italian experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.686-690

2013

Volltextzugriff (PDF)

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.700-710

2011

Volltextzugriff (PDF)

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-03, Vol.12 (2), p.128-132

2006

Volltextzugriff (PDF)

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (5), p.502-507

2007

Volltextzugriff (PDF)

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women

Metabolism, clinical and experimental, 1999-08, Vol.48 (8), p.960-964

1999

Volltextzugriff (PDF)

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation

Blood coagulation & fibrinolysis, 1999-10, Vol.10 (7), p.409

1999

Volltextzugriff (PDF)

Factor XI deficiency: two novel mutations in asymptomatic Italian patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.767-770

2010

Volltextzugriff (PDF)

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.90-95

2012

Volltextzugriff (PDF)

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections

Blood coagulation & fibrinolysis, 1999-01, Vol.10 (1), p.33-38

1999

Volltextzugriff (PDF)

Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs

The Lancet (British edition), 1992-06, Vol.339 (8807), p.1486-1487

1992

Volltextzugriff (PDF)

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-03, Vol.12 (2), p.154-162

2006

Volltextzugriff (PDF)

Defibrotide in the treatment of Raynaud's phenomenon in patients with progressive systemic sclerosis or essential mixed cryoglobulinemia

Current therapeutic research, 1993, Vol.53 (1), p.48-58

1993

Volltextzugriff (PDF)

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation

Blood coagulation & fibrinolysis, 1999-10, Vol.10 (7), p.416

1999

Volltextzugriff (PDF)

Early Treatment of Hemophilia With Minimal Doses of Factor VIII or Factor IX

Blood, 1978-04, Vol.51 (4), p.763-763

1978

Volltextzugriff (PDF)

Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients

Haemophilia : the official journal of the World Federation of Hemophilia, 1996-01, Vol.2 (1), p.37-40

1996

Volltextzugriff (PDF)

Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P0875-P0875

2003

Volltextzugriff (PDF)

The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease

Clinical and diagnostic virology, 1997-11, Vol.8 (3), p.189-194

1997

Volltextzugriff (PDF)

Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations

Blood coagulation & fibrinolysis, 2003-01, Vol.14 (1), p.95-98

2003

Volltextzugriff (PDF)

Intrafamilial and sexual transmission of hepatitis C virus

The Lancet (British edition), 1993-11, Vol.342 (8882), p.1300-1301

1993

Volltextzugriff (PDF)

Clinical Factors Associated with Progression to AIDS in the Italian Cohort of HIV-Positive Hemophiliacs

Thrombosis and haemostasis, 1994, Vol.72 (1), p.33-38

1994

Volltextzugriff (PDF)

Epidemiology of hemophilia and of HIV infection in Italy

Journal of clinical epidemiology, 1994, Vol.47 (11), p.1297-1306

1994

Volltextzugriff (PDF)

Intrafamilial and sexual transmission of hepatitis C virus

Lancet (London, England), 1993, Vol.342 (8882), p.1300-1302

1993

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: Results from a multicenter study in 47 patients

Inhibitors in haemophilia B: the Italian experience

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation

Factor XI deficiency: two novel mutations in asymptomatic Italian patients

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections

Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

Defibrotide in the treatment of Raynaud's phenomenon in patients with progressive systemic sclerosis or essential mixed cryoglobulinemia

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation

Early Treatment of Hemophilia With Minimal Doses of Factor VIII or Factor IX

Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients

Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women

The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease

Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations

Intrafamilial and sexual transmission of hepatitis C virus

Clinical Factors Associated with Progression to AIDS in the Italian Cohort of HIV-Positive Hemophiliacs

Epidemiology of hemophilia and of HIV infection in Italy

Intrafamilial and sexual transmission of hepatitis C virus

Suchergebnisse filtern